Drug Profile
Research programme: ataxia therapy - NeuroSearch
Alternative Names: NSD-801Latest Information Update: 04 Dec 2013
Price :
$50
*
At a glance
- Originator NeuroSearch
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Dyskinesias
Most Recent Events
- 28 Sep 2011 Research programme: ataxia therapy - NeuroSearch is available for licensing as of 28 Sep 2011. http://neurosearch.com
- 11 Jan 2011 Preclinical trials in Dyskinesia in Denmark (unspecified route)